Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
Crossref DOI link: https://doi.org/10.1007/s00401-015-1383-6
Published Online: 2015-01-15
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martin-Blondel, Guillaume
Bauer, Jan
Uro-Coste, Emmanuelle
Biotti, Damien
Averseng-Peaureaux, Delphine
Fabre, Nelly
Dumas, Hervé
Bonneville, Fabrice
Lassmann, Hans
Marchou, Bruno
Liblau, Roland S.
Brassat, David
Text and Data Mining valid from 2015-01-15